The Brutalist Report - yahoofinance

Yahoo Finance

Parabilis now the largest VC-backed biotech IPO [34d]
Nayax CMO sells during a solid double digit run — Execution from here is the story to watch [34d]
ICU Medical's General Counsel Sells — The Smiths Integration Is Almost Done, the Proof Isn'tICU Medical's General Counsel Sells — The Smiths Integration Is still playing out. [34d]
Review & Preview: The AI Rally Keeps Unwinding [34d]
Visa Stock: Where Compounding Could Take The Price [34d]
Why Marvell Technology Stock Sank Today [34d]
The AI Trade Nobody Is Making Right Now -- and Why It Could Be 2026's Best Opportunity [34d]
Core Scientific (CORZ) Strengthens Board With Zayo CEO Appointment [34d]
Data Centers Want to Save Water. Vertiv Holdings Co (VRT) Has a New Solution [34d]
Applied Digital Corp (APLD)’s Blue-Chip Customer Returns for More [34d]
Why Jefferies Recommends Riot Platforms Inc (RIOT) Stock [34d]
Jefferies Initiates Cipher Digital Inc (CIFR) Stock. Here’s What It’s Saying [34d]
These 2 Dividend Stocks Just Boosted Their Payouts by 13% — And More Income Growth Could Be Ahead [34d]
1 Reason to Buy the SpaceX IPO and 3 Reasons to Avoid It [34d]
Why KLA Corporation Stock Edged Past the Broader Market Today [34d]
Paradigm and Hyperliquid Policy Center Push Back on GENIUS Act Stablecoin Rule [34d]
Amphastar Pharmaceuticals Pivots to Proprietary Drugs, Biosimilars for Growth [34d]
Navan Q1 Earnings Call Highlights [34d]
Oracle Just Delivered a Record-Breaking Quarter, Complete with a Beat and Raise. So Why Is the Stock Falling? [34d]
They Want To Know At What Age Can A Typical Middle-Class Family Expect To Hit $1M In Retirement Savings. Nobody Around Them Wants To Share [34d]
Johnson & Johnson bets $1 billion on hard-to-treat cancer [34d]
Algeria’s Gas Advantage Is Real. So Are Its Production Problems. [34d]